Transglutaminase 1/TGM1 Antibody - BSA Free

Immunohistochemistry-Paraffin: Transglutaminase 1/TGM1 Antibody [NBP2-34062]

Immunohistochemistry-Paraffin: Transglutaminase 1/TGM1 Antibody [NBP2-34062] - Staining of human colon shows no positivity in glandular cells.

Immunohistochemistry-Paraffin: Transglutaminase 1/TGM1 Antibody [NBP2-34062]

Immunohistochemistry-Paraffin: Transglutaminase 1/TGM1 Antibody [NBP2-34062] - Staining of human liver shows no positivity in hepatocytes as expected.

Immunohistochemistry-Paraffin: Transglutaminase 1/TGM1 Antibody [NBP2-34062]

Immunohistochemistry-Paraffin: Transglutaminase 1/TGM1 Antibody [NBP2-34062] - Staining of human skin shows moderate membranous positivity in squamous epithelial cells.

Immunohistochemistry-Paraffin: Transglutaminase 1/TGM1 Antibody [NBP2-34062]

Immunohistochemistry-Paraffin: Transglutaminase 1/TGM1 Antibody [NBP2-34062] - Staining of human tonsil shows moderate membranous positivity in sqamous epithelial cells.

Western Blot: Transglutaminase 1/TGM1 Antibody - BSA Free [NBP2-34062] -

ATF4 and CHOP are required for efficient TPA-induced lytic EBV reactivation and differentiation in WT EBV-infected NOKs.WT EBV-infected NOKs cells were transfected with control siRNA or siRNAs against ATF4 (A and C) or CHOP (B and D) as indicated, and then treated with TPA for 24 hours starting one day after siRNA transfection. (A and B) Immunoblot analyses were performed to examine the effect of ATF4 and CHOP knock-down on lytic EBV proteins BZLF1, BRLF1, BMRF1 and p18 VCA as indicated. (C and D) Immunoblot analyses were performed to examine the effect of ATF4 and CHOP knock-down on TPA-induced differentiation markers BLIMP1, TGM1, and SPRR1A as indicated. Tubulin served as a loading control. The cellular extracts used in (A) and (C) or (B) and (D) were the same. The same ATF4 and Tubulin blots were used in (A) and (C), and the same CHOP and Tubulin blots were used for (B) and (D). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39951426), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: Transglutaminase 1/TGM1 Antibody - BSA Free [NBP2-34062] -

GCN2 is required for TPA-induced lytic EBV reactivation and differentiation in WT EBV-infected NOKs.WT EBV-infected NOKs cells were transfected with control siRNA or siRNAs against GCN2 as indicated, and then treated with TPA for 24 hours starting one day after siRNA transfection. (A) Immunoblot analysis was performed to examine the effect of GCN2 knock-down on proteins involved in the ISR pathway (including p-GCN2, GCN2, p-eIF2 alpha, eiF2 alpha, ATF4, and CHOP) and EBV lytic proteins (BZLF1, BRLF1, BMRF1, and p18 VCA). (B) Immunoblot analyses were performed to examine the effect of GCN2 knock-down on differentiation-induced cellular proteins Involucrin, BLIMP1, and TGM1. Tubulin served as a loading control for both panels. The same extracts were used for each panel, and the same GCN2, p-GCN2, and Tubulin blots were used for both panels. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39951426), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: Transglutaminase 1/TGM1 Antibody - BSA Free [NBP2-34062] -

PERK is also required for efficient TPA-induced lytic EBV reactivation and differentiation in WT EBV-infected NOKs.WT EBV-infected NOKs cells were transfected with control siRNA or siRNAs against PERK as indicated, and then treated with TPA for 24 hours starting one day after siRNA transfection. (A) Immunoblot analyses were performed to examine the effect of PERK knock-down on EBV lytic proteins BZLF1, BRLF1, and BMRF1. (B) Immunoblot analyses were performed to examine the effect of PERK knock-down on differentiation-induced cellular proteins BLIMP1, TGM1, Involucrin and SPRR1A. Tubulin served as a loading control for both panels. The same extracts were used for both panels, and the same PERK and Tubulin blots were used for both panels. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39951426), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: Transglutaminase 1/TGM1 Antibody - BSA Free [NBP2-34062] -

ATF4 and CHOP are required for efficient TPA-induced lytic EBV reactivation and differentiation in WT EBV-infected NOKs.WT EBV-infected NOKs cells were transfected with control siRNA or siRNAs against ATF4 (A and C) or CHOP (B and D) as indicated, and then treated with TPA for 24 hours starting one day after siRNA transfection. (A and B) Immunoblot analyses were performed to examine the effect of ATF4 and CHOP knock-down on lytic EBV proteins BZLF1, BRLF1, BMRF1 and p18 VCA as indicated. (C and D) Immunoblot analyses were performed to examine the effect of ATF4 and CHOP knock-down on TPA-induced differentiation markers BLIMP1, TGM1, and SPRR1A as indicated. Tubulin served as a loading control. The cellular extracts used in (A) and (C) or (B) and (D) were the same. The same ATF4 and Tubulin blots were used in (A) and (C), and the same CHOP and Tubulin blots were used for (B) and (D). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39951426), licensed under a CC-BY license. Not internally tested by Novus Biologicals.